Imipenem & Cilastatin 1g Injection Exporter from India to USA, UK, Australia, Singapore, Thailand, and Jamaica | Premium Carbapenem Antibiotic Supplier | Ernest Impex Global Medicine Logistics

Extensive Product Profile: Understanding Imipenem and Cilastatin for Injection 1 g

Imipenem and Cilastatin for Injection 1 g is a powerful, broad-spectrum carbapenem antibiotic combination. It is a sterile, pyrogen-free formulation comprising two active components: Imipenem, a potent thienamycin antibacterial agent, and Cilastatin sodium, a reversible inhibitor of the renal enzyme dehydropeptidase I. This synergistic combination is utilized in clinical settings to manage severe, complicated bacterial infections where a high level of bactericidal activity is required.

1. Clinical Indications & Usage

This combination therapy is reserved for the treatment of serious infections caused by susceptible organisms, particularly in hospital environments. Key clinical indications include:

Lower Respiratory Tract Infections: Management of severe pneumonia and infected bronchiectasis.

Urinary Tract Infections (UTIs): Treatment of complicated infections, including pyelonephritis.

Intra-Abdominal Infections: Used in the management of peritonitis, complicated appendicitis, and other intra-abdominal abscesses.

Gynecological Infections: Indicated for postpartum infections and severe endometritis.

Skin and Soft Tissue Infections: Management of severe infections, including those occurring in diabetic patients or wound complications.

Bone and Joint Infections: Used for the treatment of osteomyelitis and septic arthritis.

Systemic Infections: Management of septicemia, endocarditis, and serious infections in immunocompromised patients (e.g., febrile neutropenia).

2. Mechanism of Action

Imipenem: Acts as a bactericidal agent by binding to specific Penicillin-Binding Proteins (PBPs), primarily PBP 2, PBP 3, and PBP 4, in the bacterial cell wall. This binding inhibits peptidoglycan synthesis, leading to rapid cell wall lysis and bacterial death.

Cilastatin: This component provides no antibacterial effect itself. However, it acts as a highly specific, reversible inhibitor of the enzyme dehydropeptidase I, which is found in the renal brush border. Imipenem is normally metabolized by this enzyme in the kidneys; by inhibiting it, cilastatin prevents the inactivation of imipenem, ensuring higher, sustained therapeutic levels in the bloodstream and reducing potential renal accumulation.

3. Administration and Dosing

Route: This medication is formulated as a sterile powder for reconstitution and must be administered strictly by intravenous (IV) infusion.

Preparation: Reconstitution must be performed using compatible IV diluents (e.g., 0.9% Sodium Chloride) under aseptic conditions to maintain sterility and potency.

Dosing Guidelines: The dosage and frequency are strictly determined by a physician based on the infection site, the severity of the illness, the patient's body weight, and renal function. It is typically administered every 6 to 8 hours.

⚠️ Safety, Side Effects, and Monitoring

Hypersensitivity: Contraindicated in patients with a history of severe hypersensitivity or anaphylaxis to any carbapenem or beta-lactam antibiotic.

Neurological Safety: While rare, carbapenems can cause central nervous system (CNS) adverse events, including tremors or seizures. Clinical caution is necessary for patients with a history of CNS disorders or renal impairment.

Common Side Effects: Observed clinical side effects include nausea, vomiting, diarrhea, skin rash, and local reactions at the intravenous injection site (such as phlebitis or thrombophlebitis).

Monitoring: Clinicians must monitor for the emergence of superinfections, particularly Clostridioides difficile-associated diarrhea, and perform ongoing assessment of renal function to ensure appropriate dosage.

📦 Storage and Handling

Storage Framework: Keep vials stored in their original packaging at controlled room temperature (20°C to 25°C). The product must be kept in a dry, dark place protected from excessive heat and moisture.

Stability: The reconstituted solution should be used according to validated clinical stability protocols to ensure the injection remains sterile and fully potent.

PRESCRIPTION MEDICINE IS : YES

Clinical Disclaimer: This profile is compiled for medical professional information and clinical research. Imipenem and Cilastatin for Injection 1 g is a prescription-only medication and must be administered strictly under the supervision of a licensed physician or within a professional hospital setting. Use during pregnancy or while breastfeeding should only occur if the potential clinical benefit justifies the potential risk to the patient and fetus.

📞 Contact Ernest Impex — Pharmaceutical Exporter from India

[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]

🌐 Websites:

www.ernestimpex.com

www.oncologymedicinesupplier.com

www.ernestpharmaceuticals.com

www.ernestvision.com

📧 Email: exports@ernestpharmaceuticals.com

📦 Business Type: Exporter | Supplier | Distributor

📲 WhatsApp: +91 93599 02383

📲 WhatsApp Link: https://wa.me/919359902383